Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HORACIO A CAPOTE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1053475939
CMS profile
47415
Location
AMHERST, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$135,393.86

393 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HORACIO A CAPOTE

NPI 1053475939 · CMS profile ID 47415

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

AMHERST, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053475939?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HORACIO A CAPOTE, NPI 1053475939, CMS profile ID 47415. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053475939?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). HORACIO A CAPOTE, NPI 1053475939, CMS profile ID 47415. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053475939?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
HORACIO A CAPOTE, NPI 1053475939, CMS profile ID 47415, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1053475939?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

393 matching records · $135,393.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 393 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 393.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $1.2509/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667851 CMS
ITI, Inc. $3,780.0009/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040489023 CMS
ITI, Inc. $128.3809/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040489033 CMS
ITI, Inc. $19.3109/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040489039 CMS
Otsuka America Pharmaceutical, Inc. $2,808.0009/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257377 CMS
Azurity Pharmaceuticals, Inc. $21.0909/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988968965 CMS
ITI, Inc. $17.6209/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040489017 CMS
Janssen Pharmaceuticals, Inc $900.0009/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987891533 CMS
Otsuka America Pharmaceutical, Inc. $19.7309/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257369 CMS
Teva Pharmaceuticals USA, Inc. $17.0109/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667845 CMS
Otsuka America Pharmaceutical, Inc. $23.3409/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257361 CMS
Teva Pharmaceuticals USA, Inc. $5.3909/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667835 CMS
Teva Pharmaceuticals USA, Inc. $0.6809/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667841 CMS
Teva Pharmaceuticals USA, Inc. $2.1509/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667859 CMS
Teva Pharmaceuticals USA, Inc. $9.0009/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667863 CMS
AbbVie Inc. $7.3509/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996357433 CMS
Lundbeck LLC $16.9109/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032191169 CMS
Neurocrine Biosciences, Inc. $20.9409/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052024769 CMS
Otsuka America Pharmaceutical, Inc. $21.3609/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257353 CMS
ITI, Inc. $22.0409/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040489007 CMS
Otsuka America Pharmaceutical, Inc. $6.6409/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257349 CMS
AbbVie Inc. $22.3509/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996357431 CMS
Janssen Pharmaceuticals, Inc $32.2309/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987891573 CMS
Otsuka America Pharmaceutical, Inc. $4.6209/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257333 CMS
Otsuka America Pharmaceutical, Inc. $14.0609/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257339 CMS
Teva Pharmaceuticals USA, Inc. $8.0709/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667831 CMS
Janssen Scientific Affairs, LLC $22.7109/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988464545 CMS
ITI, Inc. $11.0509/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040489002 CMS
ITI, Inc. $24.9009/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040488991 CMS
Teva Pharmaceuticals USA, Inc. $33.9809/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667839 CMS
Alkermes, Inc. $24.5408/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022790457 CMS
Alkermes, Inc. $29.6108/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022790455 CMS
Vanda Pharmaceuticals Inc. $23.1908/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051521095 CMS
Otsuka America Pharmaceutical, Inc. $13.5808/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257311 CMS
Otsuka America Pharmaceutical, Inc. $8.1508/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257319 CMS
Otsuka America Pharmaceutical, Inc. $22.9608/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257327 CMS
Teva Pharmaceuticals USA, Inc. $17.0108/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667817 CMS
Axsome Therapeutics, Inc. $21.6308/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056157147 CMS
ITI, Inc. $2,700.0008/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040488975 CMS
ITI, Inc. $88.7208/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040488985 CMS
Janssen Pharmaceuticals, Inc $22.9408/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987891565 CMS
Otsuka America Pharmaceutical, Inc. $24.6608/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257303 CMS
Teva Pharmaceuticals USA, Inc. $8.6108/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667805 CMS
Lundbeck LLC $2.9408/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032191157 CMS
Lundbeck LLC $2.8208/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032191163 CMS
Neurocrine Biosciences, Inc. $19.5408/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052024747 CMS
Teva Pharmaceuticals USA, Inc. $31.9908/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056667813 CMS
Janssen Pharmaceuticals, Inc $350.0008/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987891517 CMS
Janssen Pharmaceuticals, Inc $25.3308/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987891588 CMS
Otsuka America Pharmaceutical, Inc. $11.1508/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014257295 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $204,584.96 427
PY2020 $52,294.26 207
PY2021 $65,176.33 312
PY2022 $121,550.91 355
PY2023 $135,393.86 393
PY2024 $252,833.39 412
PY2025 $235,000.19 365

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $199,953.28 47
PY2024 Principal investigator $137,425.06 45
PY2023 Recipient $300.00 1
PY2023 Principal investigator $38,279.90 18
PY2022 Recipient $450.00 1
PY2022 Principal investigator $30,466.95 13
PY2021 Principal investigator $142,593.13 37
PY2020 Recipient $2,700.00 3
PY2020 Principal investigator $216,502.69 51
PY2019 Recipient $14,673.00 5
PY2019 Principal investigator $409,308.18 44

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

47 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,321.27 11/21/2025 Non-covered Recipient Entity
Dent Neurologic Institute
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild-to-Moderate Alzheimers Disease (MINDSET 2) No dispute reported 06/30/2026 1235997736
Principal investigator 1 LivaNova USA, Inc. $858.00 11/11/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538349
Principal investigator 1 LivaNova USA, Inc. $97.50 11/11/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538354
Principal investigator 1 LivaNova USA, Inc. $936.00 10/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538316
Principal investigator 1 LivaNova USA, Inc. $97.50 10/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538320
Principal investigator 1 LivaNova USA, Inc. $422.50 10/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538324
Principal investigator 1 LivaNova USA, Inc. $936.00 10/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538345
Principal investigator 1 LivaNova USA, Inc. $97.50 09/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538312
Principal investigator 1 LivaNova USA, Inc. $936.00 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538295
Principal investigator 1 LivaNova USA, Inc. $97.50 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538299
Principal investigator 1 LivaNova USA, Inc. $390.00 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538303
Principal investigator 1 LivaNova USA, Inc. $292.50 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538308
Principal investigator 1 LivaNova USA, Inc. $390.00 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538328
Principal investigator 1 LivaNova USA, Inc. $390.00 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538331
Principal investigator 1 LivaNova USA, Inc. $390.00 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538337
Principal investigator 1 LivaNova USA, Inc. $390.00 08/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538341
Principal investigator 1 LivaNova USA, Inc. $1,345.00 08/07/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556288
Principal investigator 1 LivaNova USA, Inc. $90.00 06/17/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556738
Principal investigator 1 LivaNova USA, Inc. $936.00 06/10/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538245
Principal investigator 1 LivaNova USA, Inc. $585.00 06/10/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538249
Principal investigator 1 LivaNova USA, Inc. $97.50 06/10/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538253
Principal investigator 1 LivaNova USA, Inc. $292.50 06/10/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538257
Principal investigator 1 LivaNova USA, Inc. $390.00 06/10/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538261
Principal investigator 1 LivaNova USA, Inc. $936.00 06/10/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538266
Principal investigator 1 LivaNova USA, Inc. $390.00 05/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538241
Principal investigator 1 LivaNova USA, Inc. $390.00 05/09/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538285
Principal investigator 1 LivaNova USA, Inc. $858.00 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538226
Principal investigator 1 LivaNova USA, Inc. $936.00 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538230
Principal investigator 1 LivaNova USA, Inc. $97.50 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538233
Principal investigator 1 LivaNova USA, Inc. $390.00 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538236
Principal investigator 1 LivaNova USA, Inc. $97.50 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538271
Principal investigator 1 LivaNova USA, Inc. $97.50 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538275
Principal investigator 1 LivaNova USA, Inc. $390.00 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538279
Principal investigator 1 LivaNova USA, Inc. $390.00 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538289
Principal investigator 1 LivaNova USA, Inc. $858.00 04/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538292
Principal investigator 1 LivaNova USA, Inc. $936.00 03/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538214
Principal investigator 1 LivaNova USA, Inc. $97.50 03/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538218
Principal investigator 1 LivaNova USA, Inc. $390.00 03/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538222
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,183.51 02/25/2025 Non-covered Recipient Entity
Dent Neurologic Institute
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235997732
Principal investigator 1 LivaNova USA, Inc. $858.00 02/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538197
Principal investigator 1 LivaNova USA, Inc. $97.50 02/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538201
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $172,935.00 01/29/2025 Non-covered Recipient Entity
Dent Neurologic Institute
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235997734
Principal investigator 1 LivaNova USA, Inc. $858.00 01/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538185
Principal investigator 1 LivaNova USA, Inc. $936.00 01/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538189
Principal investigator 1 LivaNova USA, Inc. $97.50 01/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538193
Principal investigator 1 LivaNova USA, Inc. $97.50 01/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538206
Principal investigator 1 LivaNova USA, Inc. $858.00 01/08/2025 Non-covered Recipient Entity
Dent Neuroscience Research Center
RECOVER No dispute reported 06/30/2026 1245538210

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2025 Amount invested $27,667.29 1
PY2025 Value of interest $101,832.19 1
PY2024 Amount invested $23,870.60 1
PY2024 Value of interest $74,164.91 1
PY2023 Amount invested $12,514.72 1
PY2023 Value of interest $50,294.31 1
PY2022 Amount invested $14,136.74 1
PY2022 Value of interest $37,779.58 1
PY2021 Amount invested $8,074.57 1
PY2021 Value of interest $23,642.85 1
PY2020 Amount invested $6,933.77 1
PY2020 Value of interest $15,568.28 1
PY2019 Amount invested $8,290.25 1
PY2019 Value of interest $8,634.52 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

7 records · PY2019–2025

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2025 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $27,667.29 $101,832.19 Value of interest is a cumulative total calculated by adding year-over-year ownership values per provider. Payments are made to a group practice, not directly to the physician. We calculate ownership percentage/dollar amount invested by determining the percentage of overhead buy down per physician clinic as a result of the practice ownership in the GPO. Physician Covered Recipient No dispute reported 06/30/2026 1246668059
PY2024 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $23,870.60 $74,164.91 1.) Value of interest is a cumulative total calculated by adding year-over-year ownership values per provider. 2.) Payments are made to a group practice rather than to a specific physician. The group practice owns 50% of the GPO. We calculate ownership percentage/dollar amount invested by determining the percentage of overhead buydown per physician clinic as a result of the practice ownership in the GPO. Physician Covered Recipient No dispute reported 06/30/2026 1088918132
PY2023 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $12,514.72 $50,294.31 1.) Value of interest is a cumulative total calculated by adding year-over-year ownership values per provider. 2.) Payments are made to a group practice rather than to a specific physician. The group practice owns 50% of the GPO. We calculate ownership percentage/dollar amount invested by determining the percentage of overhead buydown per physician clinic as a result of the practice ownership in the GPO. Physician Covered Recipient No dispute reported 06/30/2026 1056936825
PY2022 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $14,136.74 $37,779.58 The organization the physician practices at owns 50% of the GPO, therefore 50% of the profit goes to the medical practice. Physician Covered Recipient No dispute reported 06/30/2026 961849323
PY2021 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $8,074.57 $23,642.85 The organization the physician practices at owns 50% of the GPO, therefore 50% of the profit goes to the medical practice. Physician Covered Recipient No dispute reported 06/30/2026 851040349
PY2020 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $6,933.77 $15,568.28 Physician is employed at outpatient neurology practice that owns a percentage of the GPO Physician Covered Recipient No dispute reported 06/30/2026 753246403
PY2019 NEUROLOGY PRACTICE CONSORTIUM GPO, LLC $8,290.25 $8,634.52 Physician is employed at outpatient neurology practice that owns a percentage of the GPO Physician Covered Recipient No dispute reported 06/30/2026 708351873